Chuck Ence - Net Worth and Insider Trading
Chuck Ence Net Worth
The estimated net worth of Chuck Ence is at least $127,042 dollars as of 2024-11-07. Chuck Ence is the CA and CO of Relmada Therapeutics Inc and owns about 38,970 shares of Relmada Therapeutics Inc (RLMD) stock worth over $127,042. Details can be seen in Chuck Ence's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Chuck Ence has not made any transactions after 2024-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Chuck Ence
Chuck Ence Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Chuck Ence owns 2 companies in total, including Relmada Therapeutics Inc (RLMD) , and NewAge Inc (NBEVQ) .
Click here to see the complete history of Chuck Ence’s form 4 insider trades.
Insider Ownership Summary of Chuck Ence
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2024-01-31 | Chief Financial Officer |
| NBEVQ | NewAge Inc | 2016-09-15 | Chief Financial Officer |
Chuck Ence Latest Holdings Summary
Chuck Ence currently owns a total of 1 stock. Chuck Ence owns 38,970 shares of Relmada Therapeutics Inc (RLMD) as of January 31, 2024, with a value of $127,042.
Latest Holdings of Chuck Ence
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RLMD | Relmada Therapeutics Inc | 2024-01-31 | 38,970 | 3.26 | 127,042 |
Holding Weightings of Chuck Ence
Chuck Ence Form 4 Trading Tracker
According to the SEC Form 4 filings, Chuck Ence has made a total of 1 transactions in Relmada Therapeutics Inc (RLMD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Relmada Therapeutics Inc is the acquisition of 38,970 shares on January 31, 2024, which cost Chuck Ence around $150,814.
Insider Trading History of Chuck Ence
- 1
Chuck Ence Trading Performance
GuruFocus tracks the stock performance after each of Chuck Ence's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Chuck Ence is -6.11%. GuruFocus also compares Chuck Ence's trading performance to market benchmark return within the same time period. The performance of stocks bought by Chuck Ence within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Chuck Ence's insider trading performs compared to the benchmark.
Performance of Chuck Ence
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 73.03 |  | | | | |
| Relative Return to S&P 500(%) | 67.02 | | | | | |
Chuck Ence Ownership Network
Ownership Network List of Chuck Ence
Ownership Network Relation of Chuck Ence
Chuck Ence Owned Company Details
What does Relmada Therapeutics Inc do?
Who are the key executives at Relmada Therapeutics Inc?
Chuck Ence is the Chief Financial Officer of Relmada Therapeutics Inc. Other key executives at Relmada Therapeutics Inc include director & Chief Executive Officer Sergio Traversa , Chief Medical Officer Cedric O'gorman , and EVP & Head of R&D Thomas Wessel .
Relmada Therapeutics Inc (RLMD) Insider Trades Summary
Over the past 18 months, Chuck Ence made 1 insider transaction in Relmada Therapeutics Inc (RLMD) with a net purchase of 38,970. Other recent insider transactions involving Relmada Therapeutics Inc (RLMD) include a net purchase of 240,000 shares made by Sergio Traversa , a net purchase of 86,107 shares made by Maged Shenouda , and a net purchase of 25,000 shares made by Paul Edward Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Relmada Therapeutics Inc (RLMD) in total and bought 231,432 shares, with a net purchase of 231,432 shares. During the past 18 months, 0 shares of Relmada Therapeutics Inc (RLMD) were sold and 413,077 shares were bought by its insiders, resulting in a net purchase of 413,077 shares.
Relmada Therapeutics Inc (RLMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Relmada Therapeutics Inc Insider Transactions
Chuck Ence Mailing Address
Above is the net worth, insider trading, and ownership report for Chuck Ence. You might contact Chuck Ence via mailing address: 3000 S. University Blvd., Denver Co 80210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
